Tonight Cramer said tonight on his MAD MONEY show on CNBC there is no reason to wait for the J.P.Morgan Biotech conference, because he already has the stocks to play.
Thermo Fisher (TMO) presents at 11:00 AM EST tomorrow, and Cramer said he would buy it around 10AM ahead of its prsentation. They are the one-stop shop for all the scientific instrument and analytic needs now. Itrecently merged with Fisher Scientific and has over 350,000 customers in over 150 countries. After tomorrow Cramer thinks you’ll see waves of analyst coverage coming into the stock. This has the arms dealer model where it sells instruments and equipment to everyone in the field and it has a small group of analysts that cover it. He likes its ability cut costs and likes its pricing power. He thinks they have also been conservative in guidance. He thinks that they could have quarterly upside for a while.
Prior to TMO, Cramer picked Gilead (GILD) as one to buy into the conference. Here is the full commentary on Gilead from Cramer.
In a call in Cramer panned Ligand Pharma (LGND) and said he wasn’t worried about a small portion of insider ownership in Genentech (DNA) and Amgen (AMGN) because they are so huge.
Jon C. Ogg
January 8, 2007